GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human PARP14 bound to 2-{[(1-methylpiperidin-4- YL)METHYL]AMINO}-5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN- 4(3H)-one inhibitor

Analyse Crystal structure of human PARP14 bound to 2-{[(1-methylpiperidin-4… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5V7W
Type
protein
Length
347 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Poly [ADP-ribose] polymerase 14
EC
2.4.2.30
UniProt
Q460N5
Ligands
91J
Pockets
2 · best druggability 0.69

Structure

x-ray diffraction · 2 distinct chains · 25% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APoly [ADP-ribose] polymerase 14 (EC 2.4.2.30)protein16927% helix, 37% strandQ460N5
BPoly [ADP-ribose] polymerase 14 (EC 2.4.2.30)protein17824% helix, 35% strandQ460N5

Ligands and binding sites

  • 91J · 2-{[(1-methylpiperidin-4-yl)methyl]amino}-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15340.690.799091J
2780.320.7414empty

Interfaces

1 interface between chains.

  • A–B · 706 Ų buried · 12 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 5V7W · Crystal structure of human PARP14 bound to 2-{[(1-methylpiperidin-4-yl)methyl]amino}-5,6,7… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.